Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Facet Biotech's board recommends shareholders reject Biogen Idec's $356 million tender offer
Facet Biotech's board recommends shareholders reject Biogen Idec's $356 million tender offer
Facet Biotech's board recommends shareholders reject Biogen Idec's $356 million tender offer
Submitted by
admin
on October 1, 2009 - 9:13am
Source:
Yahoo/AP
News Tags:
M&A
Facet Biotech
Biogen Idec
Headline:
Facet Biotech's board recommends shareholders reject Biogen Idec's $356 million tender offer
Do Not Allow Advertisers to Use My Personal information
